100 related articles for article (PubMed ID: 7701915)
1. Hemopoietic recovery from AZT toxicity with recombinant hemoglobin in a murine model of AIDS.
Moqattash S; Lutton JD; Abu-Hijleh MF; Abraham NG
Acta Haematol; 1994; 92(4):182-6. PubMed ID: 7701915
[TBL] [Abstract][Full Text] [Related]
2. Effect of blood substitute, recombinant hemoglobin, on in vivo hematopoietic recovery from AZT toxicity.
Moqattash S; Lutton JD; Rosenthal G; Abu-Hijleh MF; Abraham NG
Acta Haematol; 1997; 98(2):76-82. PubMed ID: 9286303
[TBL] [Abstract][Full Text] [Related]
3. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
[TBL] [Abstract][Full Text] [Related]
4. Microenvironmental toxicity of azidothymidine: partial sparing with hemin.
Abraham NG; Bucher D; Niranjan U; Brown AC; Lutton JD; Distenfeld A; Ahmed T; Levere RD
Blood; 1989 Jul; 74(1):139-44. PubMed ID: 2752105
[TBL] [Abstract][Full Text] [Related]
5. Specificity of heme for hemopoietic recovery from AZT toxicity.
Loewy G; Cook P; Ahmed T; Lutton JD; Nishimura M; Distenfeld A; Levere RD; Abraham NG
Hematol Pathol; 1992; 6(2):79-85. PubMed ID: 1607343
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of azidothymidine-induced erythroid toxicity by hemin and stem cell factor in immune-suppressed mice.
Hamburger AW; Chen RB
Exp Hematol; 1994 Apr; 22(4):348-52. PubMed ID: 7512046
[TBL] [Abstract][Full Text] [Related]
7. Effect of combination interleukin-3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) on hematopoiesis administered to retrovirus-infected immunodeficient mice receiving dose-escalation zidovudine (AZT).
Gallicchio VS; Hughes NK; Tse KF; Ling J; Gaines H; Bowen TE; Uluitu M
Int J Immunopharmacol; 1995 Nov; 17(11):865-78. PubMed ID: 8788116
[TBL] [Abstract][Full Text] [Related]
8. Sustained zidovudine treatment on hematopoiesis in immunodeficient mice.
Gallicchio VS; Hughes NK; Tse KF
Int J Immunopharmacol; 1993 Aug; 15(6):673-81. PubMed ID: 8407052
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS.
Ganser A; Greher J; Völkers B; Staszewski S; Hoelzer D
Exp Hematol; 1989 May; 17(4):321-5. PubMed ID: 2540017
[TBL] [Abstract][Full Text] [Related]
10. Failure of stem cell factor to ameliorate AZT-induced anemia in immunodeficient mice.
Hamburger AW; Zsebo K; Chow FP
Eur J Haematol; 1993 Mar; 50(3):172-8. PubMed ID: 7682517
[TBL] [Abstract][Full Text] [Related]
11. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
[TBL] [Abstract][Full Text] [Related]
12. Protection of 3'-azido-3'-deoxythymidine induced toxicity to murine hematopoietic progenitors (CFU-GM, BFU-E and CFU-MEG) with interleukin-1.
Gallicchio VS; Doukas MA; Hulette BC; Hughes NK; Gass C
Proc Soc Exp Biol Med; 1989 Nov; 192(2):201-4. PubMed ID: 2813453
[TBL] [Abstract][Full Text] [Related]
13. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
Chow FP; Zsebo K; Hamburger AW
Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
[TBL] [Abstract][Full Text] [Related]
14. Sustained elevation of platelet counts by long-term azidothymidine treatment of immunosuppressed mice.
Chow FP; Chen RB; Hamburger AW
J Lab Clin Med; 1993 Apr; 121(4):562-9. PubMed ID: 8454938
[TBL] [Abstract][Full Text] [Related]
15. Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment.
Harrison J; Kappas A; Levere RD; Lutton JD; Chertkov JL; Jiang S; Abraham NG
Blood; 1993 Dec; 82(12):3574-9. PubMed ID: 8260696
[TBL] [Abstract][Full Text] [Related]
16. [Demonstration of a protector effect of interleukin-1 against hematologic toxicity of azidothymidine (AZT)].
Arock M; Dedenon A; Damais C; Averlant G; Guillosson JJ
C R Seances Soc Biol Fil; 1992; 186(3):206-14. PubMed ID: 1493577
[TBL] [Abstract][Full Text] [Related]
17. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
Gallicchio VS; Hughes NK; Tse KF
Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
[TBL] [Abstract][Full Text] [Related]
18. Failure to establish long-term marrow cultures from immunodeficient mice (MAIDS): effect of zidovudine in vitro.
Tse KF; Hughes NK; Gallicchio VS
J Leukoc Biol; 1993 Jun; 53(6):658-65. PubMed ID: 8315348
[TBL] [Abstract][Full Text] [Related]
19. Azidothymidine and interferon-alpha in vitro effects on hematopoiesis: protective in vitro activity of IL-1 and GM-CSF.
Castello G; Mela G; Cerruti A; Mencoboni M; Lerza R
Exp Hematol; 1995 Dec; 23(13):1367-71. PubMed ID: 7498365
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of erythroid progenitor colonies to erythropoietin in azidothymidine treated immunodeficient mice.
Chow FP; Sutton PA; Hamburger AW
Br J Haematol; 1991 Feb; 77(2):139-44. PubMed ID: 2004015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
